Clinical trial
Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance
NCT00060866 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00060866 |
|---|---|
| Title | Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance |
| Official title | Propranolol for Syncope With Sympathoadrenal Imbalance |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neurocardiogenic Syncope |
| Intervention type | Drug |
| Interventions | Propranolol |
| Enrollment | 24 |
| Start date | May 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | May 15, 2003 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: